Cargando…
Emerging treatment strategies for glioblastoma multiforme
Glioblastoma multiforme (GBM) is the deadliest form of brain tumor with a more than 90% 5-year mortality. GBM has a paltry median survival of 12.6 months attributed to the unique treatment limitations such as the high average age of onset, tumor location, and poor current understandings of the tumor...
Autores principales: | Carlsson, Steven K, Brothers, Shaun P, Wahlestedt, Claes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237465/ https://www.ncbi.nlm.nih.gov/pubmed/25312641 http://dx.doi.org/10.15252/emmm.201302627 |
Ejemplares similares
-
Therapeutic potential of neuropeptide Y (NPY) receptor ligands
por: Brothers, Shaun P, et al.
Publicado: (2010) -
Precision medicine in the treatment stratification of AML patients: challenges and progress
por: Lohse, Ines, et al.
Publicado: (2018) -
Hyperbaric oxygen therapy as adjunctive strategy in treatment of glioblastoma multiforme
por: Huang, Lei, et al.
Publicado: (2018) -
Current promising treatment strategy for glioblastoma multiform: A review
por: Bahadur, Sanjib, et al.
Publicado: (2019) -
Nanotechnology for Treatment of Glioblastoma Multiforme
por: Michael, Justin S., et al.
Publicado: (2018)